AstraZeneca (AZN) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AstraZeneca

    NASDAQ: AZN · Real-Time Price · USD
    81.70
    -0.08 (-0.10%)
    At close: Sep 05, 2025, 3:59 PM
    81.97
    0.33%
    After-hours: Sep 05, 2025, 07:44 PM EDT

    AstraZeneca Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 54.07B 45.81B 44.35B 37.42B
    Cost of Revenue
    		 10.21B 8.04B 12.39B 12.44B
    Gross Profit
    		 43.87B 37.77B 31.96B 24.98B
    Operating Income
    		 10B 8.19B 3.76B 1.06B
    Interest Income
    		 345M 301M 95M 43M
    Pretax Income
    		 8.69B 6.9B 2.5B -265M
    Net Income
    		 7.04B 5.96B 3.29B 112M
    Selling & General & Admin
    		 20.22B 18.22B 18.95B 15.68B
    Research & Development
    		 13.58B 10.94B 9.76B 9.74B
    Other Expenses
    		 56M 618M -514M -1.49B
    Operating Expenses
    		 33.86B 29.58B 28.2B 23.92B
    Interest Expense
    		 1.68B 1.59B 1.35B 1.28B
    Selling & Marketing Expenses
    		 555M 539M 18.95B 15.68B
    Cost & Expenses
    		 44.07B 37.62B 40.59B 36.36B
    Income Tax Expense
    		 1.65B 938M -792M -380M
    Shares Outstanding (Basic)
    		 3.1B 3.12B 3.1B 2.84B
    Shares Outstanding (Diluted)
    		 3.13B 3.12B 3.12B 2.85B
    EPS (Basic)
    		 2.27 1.91 1.06 0.04
    EPS (Diluted)
    		 2.25 1.91 1.06 0.04
    EBITDA
    		 15.44B 13.91B 9.09B 5.11B
    EBIT
    		 10.43B 8.53B 3.83B 1.01B
    Depreciation & Amortization
    		 5.07B 4.93B 5.25B 4.1B

    Add to Watchlist